SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-002416
Filing Date
2022-03-01
Accepted
2022-03-01 07:31:54
Documents
14
Period of Report
2022-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fmtx-20220301.htm   iXBRL 8-K 62909
2 EX-99.1 fmtx-ex99_1.htm EX-99.1 202656
3 GRAPHIC img34360058_0.jpg GRAPHIC 3563
  Complete submission text file 0000950170-22-002416.txt   413439

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fmtx-20220301.xsd EX-101.SCH 2527
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fmtx-20220301_pre.xml EX-101.PRE 11620
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fmtx-20220301_lab.xml EX-101.LAB 18794
8 EXTRACTED XBRL INSTANCE DOCUMENT fmtx-20220301_htm.xml XML 4725
Mailing Address 300 NORTH BEACON STREET SUITE 501 WATERTOWN MA 02472
Business Address 300 NORTH BEACON STREET SUITE 501 WATERTOWN MA 02472 617-679-1970
Forma Therapeutics Holdings, Inc. (Filer) CIK: 0001538927 (see all company filings)

IRS No.: 371657129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39333 | Film No.: 22693954
SIC: 2836 Biological Products, (No Diagnostic Substances)